Pneumonia in immunosuppressed patients
|
|
- Bryce Harvey
- 6 years ago
- Views:
Transcription
1 Blackwell Science, LtdOxford, UKRESRespirology Blackwell Science Asia Pty LtdMarch 20049S1S25S29Original ArticlePneumonia in immunosuppressed patientss Kohno et al. Respirology (2004) 9, S25 S29 CHAPTER 6 Pneumonia in immunosuppressed patients The committee for The Japanese Respiratory Society guidelines in management of respiratory infections The Japanese Respiratory Society Pneumonia in immunosuppressed patients The committee for The Japanese Respiratory Society guidelines in management of respiratory infections. Respirology 2004; 9: S25 S29 WHAT IS IMMUNOSUPPRESSION? Immunosuppression occurs as a result of a lack of either humoral (B-cell) immunity or cellular (T-cell) immunity, or both. While immunosuppression plays a central role in susceptibility to infectious diseases in humans, neutropenia is another important contributing factor. In this chapter, immunosuppression in its broad sense will be discussed, including lack of neutrophil-mediated immunity as well as lack of humoral (B-cell) immunity and cellular (T-cell) immunity. Patients develop a variety of infectious diseases as a result of immunosuppression, and the lung is one of the most susceptible vital organs. TYPES OF IMMUNOSUPPRESSION AND FEATURES OF PNEUMONIA IN IMMUNODEFICIENT PATIENTS 1 Neutropenic patients often have fevers but seldom exhibit pneumonia-related symptoms. The chest X-rays of neutropenic patients rarely show evidence of infiltration, and such patients seldom produce purulent sputum. 1 The severity and duration of the neutropenia affects patients susceptibility to pneumonia and the prevalence of causative microorganisms. 2,3 (i) Severity of neutropenia Neutrophil count 1000/mL: Patients begin to show susceptibility to infection. Neutrophil count 500/mL: Patients show striking susceptibility to infection. Neutrophil count 100/mL: Patients have almost completely lost neutrophil-mediated defence functions. (ii) Duration of neutropenia No more than a few days: Susceptibility to infection low, seldom presents with clinical problems. Less than 3 weeks: Patients show increased risk of bacterial infection(s). More than 3 weeks: Patients show increased frequency of fungal infection as well bacterial infection. 2 The major high risk factors for neutropenia are shown below (i) Primary neutropenia: Genetically inherited neutropenia and periodic neutropenia are wellknown, but their incidence is low. (ii) Secondary neutropenia: associated with acute leukaemia and aplastic anaemia. (iii) Iatrogenic neutropenia: associated with the use of myelosuppressive anticancer chemotherapy, radiation therapy, and bone marrow transplantation, as well as with drug-induced granulocytopenia. 3 commonly associated with neutropenic patients and pneumonia Most causative agents of pneumonia in neutropenic patients are bacteria that proliferate extracellularly (primarily pyogenic bacteria) and fungi (Aspergillus in particular). Other bacteria are rarely associated with pneumonia in neutropenic patients. (i) Gram-positive bacteria: including Staphylococcus aureus and pneumoniae. Gram-negative bacteria: including Pseudomonas aeruginosa, Klebsiella and E. coli. (ii) : including Aspergillus and Mucor. Humoral immunosuppression The committee for The Japanese Respiratory Society guidelines in management of respiratory infections, Kanda, Chiyoda-ku, Tokyo , Japan. 1 Three types of humoral immunosuppression are known: lack of immunoglobulins as a whole, lack of a specific subclass of immunoglobulins, and defec-
2 S26 tive immune response to specific antigens. Most humoral immunosuppression occurs as a result of impaired IgG synthesis in vivo. 4 (i) Severity of the decreased IgG level 5 More than 500 mg/dl: Patients seldom develop infection(s) mg/dl: Patients begin to show susceptibility to infection. Less than 200 mg/dl: Patients show increased susceptibility to infection paralleling the decrease in serum immunoglobulin level. 2 The major high-risk factors for humoral immunosuppression are shown below. (i) Primary humoral immunosuppression: Severe complex humoral immunodeficiency syndrome and X-chromosome linked agammaglobulinaemia are well-known forms of primary humoral immunodeficiency, but their incidence is low. (ii) Secondary humoral immunosuppression: multiple myeloma, chronic lymphocytic leukaemia, some types of malignant lymphoma, some cases of HIV infection, severe nephrotic syndrome, burns, and protein-losing enteropathy. (iii) Iatrogenic neutropenia: humoral immunosuppression associated with the use of myelosuppressive anticancer chemotherapy, radiation therapy, and bone marrow transplantation. 3 commonly associated with humoral immunosuppression and pneumonia: Since opsonization via attachment of antibodies on the organisms, production of neutrophil chemotactic factor and complement activation are impaired, the host s defences against capsule-containing bacteria which correlate with opsonizing antibodies are primarily impaired. Other bacteria are rarely associated with hospital-associated pneumonia in patients with humoral immunosuppression. : includes pneumoniae, H. influenzae and Klebsiella. Cellular immunosuppression 1 The CD4-positive lymphocyte counts of patients with cellular immunosuppression affect their susceptibility to pneumonia and the prevalence of causative microorganisms. 6 Table 1 shows the corre- S Kohno et al. lation between CD4-positive lymphocyte counts and prevalent disorders among patients with HIV infection. (i) Severity of lymphopenia (CD4-positive lymphocyte count) CD4-positive lymphocyte count 500/mL: Patients do not show any particular susceptibility to infection. Common bacterial pneumonia is seen. CD4-positive lymphocyte count < 500/mL: Patients develop tuberculosis and cryptococcosis more frequently than healthy individuals. CD4-positive lymphocyte count 200/mL: Patients are susceptible to opportunistic pneumonia caused by a variety of pathogenic microorganisms, including viruses and parasites. CD4-positive lymphocyte count 50/mL: Patients have almost completely lost CD4-positive lymphocyte-mediated defence function. 2 The major high risk factors for cellular immunosuppression are shown below. (i) Primary cellular immunodeficiency: DiGeorge syndrome and other disorders are known, but the incidence of these diseases is low. (ii) Secondary cellular immunosuppression: including HIV infection, Hodgkin s disease, chronic lymphocytic leukaemia and some types of malignant lymphoma, etc. (iii) Iatrogenic cellular immunosuppression: cellular immunosuppression associated with the use of adrenocortical steroid preparations, immunosuppressive agents, myelosuppressive anticancer chemotherapy, radiation therapy, bone marrow transplantation and organ transplantation. 3 Common bacteria associated with cellular immunosuppression and pneumonia: Reduced CD4-positive lymphocyte counts result in defects of cytokine production. As a result, macrophage activation is impaired, which leads to loss of bactericidal activity. Patients with cellular immunosuppression become susceptible to pneumonia caused by these microorganisms, and once they develop pneumonia it becomes severe. CD4-positive lymphocytes also induce the differentiation of B- lymphocytes and natural killer cells, and this activity is also impaired. As a result, humoral immunity and the elimination of virus-infected cells (i.e. the immunological defence system) are also impaired. Because Table 1 CD4-positive lymphocyte count and prevalent pulmonary lesions in HIV-positive patients CD4-positive lymphocyte count CD4-positive lymphocytes 500/mL CD4-positive lymphocytes 200/mL CD4-positive lymphocytes 50/mL Prevalent pulmonary lesions l pneumonia ( pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa) Tuberculosis (typical pathological conditions if CD4- positive lymphocytes 200/mL, atypical pathological conditions if CD4-positive lymphocytes < 200/mL Kaposi s sarcoma (preceded by dermatological lesions) Pneumocystis carinii pneumonia Cryptococcosis (pulmonary lesion is part of systemic infection) Toxoplasmosis (pulmonary lesion is part of systemic infection) Malignant lymphoma (pulmonary lesion is part of systemic lesions) pneumonia (pulmonary lesion is part of systemic infection) Non-tuberculous atypical mycobacteriosis (rarely restricted to the pulmonary lesion)
3 Pneumonia in immunosuppressed patients of this, a variety of causative microorganisms have been isolated from pneumonia patients with cellular immunosuppression. (i) : pneumoniae, Pseudomonas aeruginosa, Legionella, Nocardia and Mycobacterium. (ii) Viruses: and herpes simplex virus. (iii) : Pneumocystis carinii, Aspergillus, Cryptococcus, mucor and candida. (iv) Protozoa and parasites: including Toxoplasma and Strongyloides stercoralis. DIAGNOSIS OF PNEUMONIA IN PATIENTS WITH IMMUNOSUPPRESSION (Fig. 1) Primary examination S27 1 If a patient is suspected of having pneumonia based on their presenting history, symptoms (cough, sputum, fever, dyspnoea, chest pain, etc.), leukocytosis, elevation of CRP, or infiltration on chest X-rays (as shown in Table 2), the primary examinations listed below should be performed, and immunosuppression should be assessed in accordance with the following criteria: (i) Neutrophil count 500/mL. (ii) Humoral immunosuppression IgG 500 mg/dl. (iii) Cellular immunosuppression CD4-positive lymphocyte count 200/mL. 2 Primary examination Haematological examinations (with a haemocytometer): WBC counts (leukocyte counts), leukocyte fractions, CD4-positive lymphocyte counts, CD8- positive lymphocyte counts, CD4/CD8 ratio, and CRP (C-reactive protein). (i) Erythrocyte sedimentation rate (ESR): ESR at one hour. (ii) Immunoglobulins: IgG, IgA, and IgE. (iii) Blood gas analysis (iv) Chest X-ray: posteroanterior and lateral (v) Microbiological examinations Primary examinations Hematological examinations WBC count and leukocyte fractions CD4, CD8, and CD4/ CD8 ratio CRP ESR IgG Blood gases Chest X-ray Microbiological examinations General bacterial, acid-fast bacterial, fungal, and blood culture Neutrophil count 500/µl Staphylococcus aureus, pneumoniae, Pseudomonas aeruginosa, Klebsiella, and E. coli Aspergillus and Mucor Itraconazole + 3rd generation cephems or 4th generation cephems or carbapenems Pneumonia IgG 500 mg/dl Humoral immunodeficiency Haemophilus influenzae, pneumoniae, and Klebsiella Immunoglobulin + 3rd generation cephems or 4th generation cephems or carbapenems CD4-positive lymphocyte counts 200/µl Cellular immunosuppression pneumoniae, Haemophilus influenzae, Pseudomonas aeruginosa, Nocardia, and mycobacterium Virus Pneumocystis carinii, Cryptococcus, and Aspergillus Secondary examinations Imaging CT Antigen tests : Legionella : b-glucan, Aspergillus, Cryptococcus, Candida Virus: PCR:, Mycobacterium, and Pneumocystis carinii Skin reactions Tuberculin-reaction Invasive examinations Bronchoscopy: Bronchoalveolar lavage, brushing, curettage, and biopsy Bilateral infiltration and/or PaO 2 70 Torr ST mixture + Fluoroquinolones + Itraconazole + 3rd generation cephems or 4th generation cephems or carbapenems Others Itraconazole + 3rd generation cephems or 4th generation cephems or carbapenems Figure 1 Flowchart for diagnosis, treatment and laboratory tests for hospital-acquired pneumonia among patients with immunosuppression.
4 S28 S Kohno et al. Table 2 Causative microorganisms responsible for infiltration seen on chest X-ray Characteristics of infiltration Classification Causative microorganisms Infiltration Nodular infiltration Cavity formation Diffuse interstitial infiltration Fungus Virus Fungus Common bacteria, Legionella (multiple infiltration), Mycobacterium tuberculosis (miliary infiltration, characterized by numerous tiny densities on radiographs) Cryptococcus Nocardia Aspergillus, Cryptococcus, and Mucor Staphylococcus aureus, Klebsiella, Pseudomonas aeruginosa Nocardia, and Mycobacterium tuberculosis Aspergillus Pneumocystis carinii Sputum culture general bacterial smear. Sputum culture acid-fast bacterial smear. Sputum culture fungal smear. Blood culture. 3 Secondary examinations If a patient is diagnosed with immunosuppression (neutropenia, decreased IgG level and/or decreased CD4-positive lymphocyte count), empiric therapy should be instituted based upon the result of the primary examination. The following secondary assessments should be performed in parallel to isolate and identify the causative microorganisms. Secondary examinations 1 Diagnostic imaging: CT (computed tomography). 2 Antigen tests (i) : Urinary Legionella antigen level: sensitivity and specificity 90%. (ii) : b-d-glucan: If positive for b-d-glucan ( 20 pg/ ml), fungal infection or Pneumocystis carinii infection should be suspected. However, false-positive responses are also noted for Cryptococcus. Aspergillus antigen: high specificity but low sensitivity; (iii) Cryptococcus antigen: sensitivity = 90%, specificity = 90%. (iv) Candida antigen: Sensitivity and specificity are both poor. (v) Viruses: cytomegalovirus antigen (viraemia or antigenaemia assay). (vi) PCR: cytomegalovirus; Mycobacterium: Mycobacterium tuberculosis and atypical mycobacterium; Pneumocystis carinii. 3 Skin reactions Tuberculin reaction: False-negative responses are often noted in patients with cellular immunosuppression, and the tuberculin test is not reliable. 4 Invasive examinations Bronchoscopy: Bronchoalveolar lavage (BAL), brushing, curettage, and lung biopsy (TBLB). Problems associated with assessing immunosuppressed patients with pneumonia 1 When immunosuppressed patients develop pneumonia, there may be more than one microorganism involved. Since more than one microorganism can be simultaneously involved, always keep in mind that multiple microorganisms may cause pneumonia. 2 Colonisation by pathogenic microorganism is frequently noted in patients with immunosuppression. Consequently, in many patients with immunosuppression, the bacteria isolated are not necessarily the causative microorganism. (i) Microorganisms where there is little doubt that they are the causative agents. : Legionella, Mycobacterium tuberculosis; : Pneumocystis carinii, Cryptococcus and Mucor. (ii) There is a possibility that the microorganisms isolated are not the causative agents. : MRSA, Pseudomonas aeruginosa andnon-tuberculosis Mycobacterium (atypical mycobacterium). : Candida. Viruses: cytomegalovirus (particularly in AIDS). EMPIRIC THERAPY FOR PNEUMONIA IN IMMUNOSUPPRESSED PATIENTS (I.E. TREATMENT BASED ON THE RESULTS OF PRIMARY EXAMINATION) 1 Generally, common bacteria and fungi are often the causative microorganisms in hospital-acquired pneumonia in a setting of neutropenia, and since the pneumonia may very rapidly worsen, empiric therapy with the antibacterial agents listed below must be instituted immediately.; (i) If the neutrophil count is between 500/mL and 1000/mL, one of the following should be used:
5 Pneumonia in immunosuppressed patients (ii) If the neutrophil count is below 500/mL, one of Itraconazole + one of the following; Third generation cephem antibiotics + aminoglycosides; G-CSF facilitates improvement of pneumoniarelated symptoms by shortening the duration of neutropenia. 7 Humoral immunosuppression 1 In most patients with humoral immunosuppression, bacteria are the cause of the pneumonia. In addition, the prevalence of H. influenzae and pneumoniae is quite high. Approximately 10 20% of H. influenzae are b-lactamase-producing strains, and non-b-lactamase-producing ampicillinresistant H. influenzae (BLNAR) strains constitute approximately 30% of the bacterial strains isolated from clinical specimens. 8 It has been reported that approximately 50% of pneumoniae strains have poor sensitivity to penicillin (PISP) or are resistant to penicillin (PRSP). 9 In view of the current situation, the following empiric therapy should be selected. (i) If the IgG level is no more than 500 mg/dl, one of Immunoglobulin + one of the following; Cellular immunosuppression 1 A wide variety of pathogenic microorganisms may cause pneumonia in patients with cellular immunosuppression, making it impossible to select empiric therapy that is effective against all of them. For this reason, empiric therapy should be instituted taking common bacteria as well as Pneumocystis carinii and Legionella (which cause rapidly progressive pneumonia) into consideration; (i) If the CD4-positive lymphocyte count is between 200/mL and 500/mL, one of the following antibiotics should be used: S29 (ii) If the CD4-positive lymphocyte count is less than 200/mL or if bilateral infiltration is seen on the chest X-ray and/or PaO 2 is 70 Torr, one of the following combinations should be used: ST mixture 12 tablets/day + Fluoroquinolone + Itraconazole + one of the following; (iii) If the above criteria are not applicable, one of Itraconazole + one of the following: Carbapenems. REFERENCES 1 Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch. Intern. Med. 1975; 135: Bodey GP, Buckley M, Sathe YS et al. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 1966; 64: Gerson SL, Talbot GH, Hurwitz S et al. Prolonged granulocyto-penia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann. Intern. Med. 1984; 100: Shelhamer JH, Toews GB, Masur H et al. Respiratory disease in the immunosuppressed patient. Ann. Intern. Med. 1992; 117: Schiff RI. Treatment of primary immunodeficiency diseases with gammaglobulin. In: Lee M, Strand V (eds). Intravenous Immunoglobulins in Clinical Practice. Marcel Dekker, New York, 1997; Masur H, Ognibene FP, Yarchoan R et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1989; 111: Mather DW, Lieschke GJ, Green M et al. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann. Intern. Med. 1994; 121: Ubukata K. Isolates from specimens sent by members of Study Groups and the drug sensitivity of the isolates. Jpn J. Antibiot 1998; 52: Matsumoto K, Shiraishi T, Rikimaru T et al. Resistance against oral antibiotics to pneumoniae isolated from adult respiratory tract infections. Jpn J. Antibiot 1999; 73:
Hospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationECMM Excellence Centers Quality Audit
ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected
More informationInfections in immunocompromised host
Infections in immunocompromised host Immunodeficiencies Primary immunodeficiencies Neutrophil defect Humoral: B cell defect Humoral: Complement Cellular: T cells Combined severe immunodeficiency Secondary
More information11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.
The spectrum of pulmonary diseases in HIV-infected persons is broad. HIV-associated Opportunistic infections Neoplasms Miscellaneous conditions Non HIV-associated Antiretroviral therapy (ART)-associated
More informationProblem 7 Unit 6 Clinical: Primary immunodeficiency
Problem 7 Unit 6 Clinical: Primary immunodeficiency THE IMMUNE SYSTEM - Function: recognizing pathogens (foreign non-self antigens) and organizing a defense response against them by facilitating destruction
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationPneumonia in the Immunocompromised Host
SIOP PODC Supportive Care Education Presentation Date: 26 th October 2015 Recording Link at www.cure4kids.org: https://www.cure4kids.org/ums/home/conference_rooms/enter.php?room=p1bk39ernlb Pneumonia in
More informationPNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT
Dr Marie Bruyneel and Deborah Konopnicki BVIKM/SBMIC November 8th, 2012 PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT Men, 54 years Emergency room on end october 2009 Sent by his family doctor for Influenza
More informationDr Marie Bruyneel and Deborah Konopnicki. BVIKM/SBMIC November 8th, 2012
Dr Marie Bruyneel and Deborah Konopnicki BVIKM/SBMIC November 8th, 2012 Men, 54 years Emergency room on end october 2009 Sent by his family doctor for Influenza A H1N1? Viral syndrom, cough, fever 39 (7j)
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationThe Pulmonary Pathology of Iatrogenic Immunosuppression. Kevin O. Leslie, M.D. Mayo Clinic Scottsdale
The Pulmonary Pathology of Iatrogenic Immunosuppression Kevin O. Leslie, M.D. Mayo Clinic Scottsdale The indications for iatrogenic immunosuppression Autoimmune/inflammatory disease Chemotherapy for malignant
More informationDisorders of immune system in hematology Stomatologic complications of treatment in hematology. Semminar for students E.Faber
Disorders of immune system in hematology Stomatologic complications of treatment in hematology Semminar for students E.Faber Topics Disorders of immune system in hematology Principles of treatment in hematology
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationCausative microorganisms of hospital-acquired pneumonia and laboratory procedures for isolation and identification of causative microorganisms
Blackwell Science, LtdOxford, UKRESRespirology1323-77992004 Blackwell Science Asia Pty LtdMarch 20049S1S6S12Original Article S Kohno et al. Respirology (2004) 9, S6 S12 CHAPTER 3 and laboratory procedures
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationPotential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections.
In the name of God Principles of post Tx infections 1: Potential etiologies of infection in these patients are diverse, including common and uncommon opportunistic infections. Infection processes can progress
More informationAppropriate utilization of the microbiology laboratory. 11 April 2013
Appropriate utilization of the microbiology laboratory 11 April 2013 Lecture Plan Revision of infectious disease Triad of infectious disease Interaction between host and infectious agent Pathogenesis Phases
More informationImmunocompromised patients. Immunocompromised patients. Immunocompromised patients
Value of CT in Early Pneumonia in Immunocompromised Patients Nantaka Kiranantawat, PSU Preventative Factors Phagocyts Cellular immunity Humoral immunity Predisposing Factors Infection, Stress, Poor nutrition,
More informationTurkish Thoracic Society
Türk Toraks Derneği Turkish Thoracic Society Turkish Thoracic Society Pocket Books Series Diagnosis and of Pneumonia in Immunocompromised Children Short Version (Handbook) in English www.toraks.org.tr
More informationPekka Riikonen. Introduction
Recombinant Human Granulocyte-Macrophage Colony-S timulating Factor in Combination with Antibiotics in the Treatment of Febrile Neutropenia in Children Pekka Riikonen Kuopio University Hospital, Division
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationmedical monitoring: clinical monitoring and laboratory tests
medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationSecondary Immunodeficiency
A guide for patients, their families, friends and healthcare professionals Raising awareness and supporting patients with immunodeficiencies in Australia. Secondary Immunodeficiency Edition 1 Date 15 th
More informationCase 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1
TB or Not TB? Case 1 Gisela Schecter, M.D., M.P.H. California Department of Public Health Background 26 year old African American male Born and raised in Bay Area of California Convicted of cocaine trafficking
More informationNeutropenic Sepsis Guideline
Neutropenic Sepsis Guideline Neutropenic Sepsis Guideline - definitions Suspected or proven infection in a neutropenic patient is a MEDICAL EMERGENCY and is an indication for immediate assessment and prompt
More informationNeutropenic Fever. CID 2011; 52 (4):e56-e93
Neutropenic Fever www.idsociety.org CID 2011; 52 (4):e56-e93 Definitions Fever: Single oral temperature of 101 F (38.3 C) Temperature 100.4 F (38.0 C) over 1 hour Neutropenia: ANC < 500 cells/mm 3 Expected
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationPneumonia. Definition of pneumonia Infection of the lung parenchyma Usually bacterial
Pneumonia Definition of pneumonia Infection of the lung parenchyma Usually bacterial Epidemiology of pneumonia Commonest infectious cause of death in the UK and USA Incidence - 5-11 per 1000 per year Worse
More informationBronchiectasis in Adults - Suspected
Bronchiectasis in Adults - Suspected Clinical symptoms which may indicate bronchiectasis for patients Take full respiratory history including presenting symptoms, past medical & family history Factors
More informationNEONATAL SEPSIS. Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI-RSCM
NEONATAL SEPSIS Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI- Background Neonatal sepsis : Early-onset Late-onset Early-onset : mostly premature neonates Within 24 hours 85% 24-48 hours
More informationChapter 11. Hyper IgM Syndromes
Chapter 11 Hyper IgM Syndromes Patients with Hyper-IgM (HIGM) syndrome are susceptible to recurrent and severe infections and in some types of HIGM syndrome opportunistic infections and an increased risk
More informationCommon Fungi. Catherine Diamond MD MPH
Common Fungi Catherine Diamond MD MPH Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr Clinically Common Fungi Yeast Mold
More informationImmunology and the middle ear Andrew Riordan
Immunology and the middle ear Andrew Riordan The Immune system is NOT there; To baffle medical students To keep Immunologists in a job To encourage experiments on mice The Immune system IS there as a defence
More informationEastern Mediterranean Health Journal, Vol. 14, No. 5,
Eastern Mediterranean Health Journal, Vol. 14, No. 5, 2008 1217 Case report Inappropriate use of steroid and Pneumocystis jiroveci pneumonia: report of two cases P. Tabarsi, 1 M. Mirsaeidi, 1 M. Amiri,
More informationFungal infection in the immunocompromised patient. Dr Kirsty Dodgson
Fungal infection in the immunocompromised patient Dr Kirsty Dodgson Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations Fungus Includes Moulds Aspergillus
More informationClinical Practice Guidelines for Nursing- and Healthcareassociated Pneumonia (NHCAP) [Complete translation] $
respiratory investigation 51 (2013) 103 126 Contents lists available at SciVerse ScienceDirect Respiratory Investigation journal homepage: www.elsevier.com/locate/resinv Guideline Clinical Practice Guidelines
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationPULMONARY MEDICINE BOARD REVIEW. Financial Conflicts of Interest. Question #1: Question #1 (Cont.): None. Christopher H. Fanta, M.D.
PULMONARY MEDICINE BOARD REVIEW Christopher H. Fanta, M.D. Pulmonary and Critical Care Division Brigham and Women s Hospital Partners Asthma Center Harvard Medical School Financial Conflicts of Interest
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationClinical Manifestations of HIV
HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationClinical Aspect and Application of Laboratory Test in Herpes Virus Infection. Masoud Mardani M.D,FIDSA
Clinical Aspect and Application of Laboratory Test in Herpes Virus Infection Masoud Mardani M.D,FIDSA Shahidhid Bh BeheshtiMdi Medical lui Universityit Cytomegalovirus (CMV), Epstein Barr Virus(EBV), Herpes
More information* MILIARY MOTTLING --
* MILIARY MOTTLING -- RARE CAUSE DR ARATHI SRINIVASAN FELLOW IN PEDIATRIC HEMATO ONCOLOGY DR A ANDAL DEPARTMENT OF PEDIATRICS DR JULIUS XAVIER SCOTT DEPARTMENT OF PEDIATRIC HEMATO ONCOLOGY KANCHI KAMAKOTI
More informationBacterial Mechanisms of Pathogenicity. 2 nd Lecture
Bacterial Mechanisms of Pathogenicity 2 nd Lecture Preferred Portal of Entry Just because a pathogen enters your body it does not mean it s going to cause disease. pathogens - preferred portal of entry
More informationAntimicrobial Management of Febrile Neutropenic Sepsis
Antimicrobial Management of Febrile Neutropenic Sepsis Written by: Dr J Joseph, Consultant Haematologist Dr K Gajee, Consultant Microbiologist Amended by: Larissa Claybourn, Antimicrobial Pharmacist Date:
More informationPneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)
Introduction Pneumocystis Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated
More information2. Clinical Manifestations (Pediatric HIV Infection)
Page 1 of 6 HOUSTON ROMANIA SOUTHERN AFRICA MEXICO HOME CONTACT Friday, July 25, 2003 Pediatric HIV Infection by Mark W. Kline, M.D. 1. Introduction 2. Clinical Manifestations 3. Diagnosis 2. Clinical
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease
Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006
More informationPNEUMONIA. I. Background 6 th most common cause of death in U.S. Most common cause of infection related mortality
Page 1 of 8 September 4, 2001 Donald P. Levine, M.D. University Health Center Suite 5C Office: 577-0348 dlevine@intmed.wayne.edu Assigned reading: pages 153-160; 553-563 PNEUMONIA the most widespread and
More informationHelminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza
Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii Ringworm fungus HIV Influenza Candida Staph aureus Mycobacterium tuberculosis Listeria Salmonella Streptococcus Levels
More informationAnalysis of the common opportunistic pathogens
2009 12 4 4 Journal of Microbes and Infection, December 2009, Vol. 4, No. 4 241 1, 3 1, 2, 3, 1. ( ), 201508; 2., 200040; 3., 200032 :,,,,,,, ;, : ; ; Analysis of the common opportunistic pathogens SUN
More informationSimultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR (1167)
From the Japanese Association of Medical Sciences The Japanese Association for Infectious Diseases Simultaneous and Rapid Detection of Causative Pathogens in Community-acquired Pneumonia by Real-time PCR
More informationMedical monitoring: tests available at central hospitals
medial monitoring: tests available at central hospitals: 1 medical monitoring: tests available at central hospitals Medical monitoring: tests available at central hospitals medial monitoring: tests available
More informationOSTEOMYELITIS. If it occurs in adults, then the axial skeleton is the usual site.
OSTEOMYELITIS Introduction Osteomyelitis is an acute or chronic inflammatory process of the bone and its structures secondary to infection with pyogenic organisms. Pathophysiology Osteomyelitis may be
More informationAntimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association
Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk
More informationClinical & Laboratory Assessment
Clinical & Laboratory Assessment Dr Roger Pool NHLS & University of Pretoria Clinical Assessment (History) Anaemia ( haemoglobin) Dyspnoea (shortness of breath) Tiredness Angina Headache Clinical Assessment
More informationImmunological disturbances in Good s syndrome
CLINICAL REPORT Immunological disturbances in Good s syndrome Justyna Fijolek * MD PhD Elzbieta Wiatr * Urszula Demkow ** Tadeusz Maria Orlowski * * Institute of Tuberculosis and Lung Diseases Warsaw Poland.
More informationHIV-related respiratory conditions
HIV-related respiratory conditions 3 Rossana A. Ditangco Head, AIDS Research Group Department of Health, Research Institute for Tropical Medicine, Philippines The respiratory system is one of the most
More informationImmunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency
Immunology Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency Transplant Immunology Transplantation is the process of moving cells, tissues or organs from one site to another
More informationQuestion 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?
Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes
More informationImmunodeficiency. By Dr. Gouse Mohiddin Shaik
Immunodeficiency By Dr. Gouse Mohiddin Shaik Immunodeficieny Immunodeficiency is failure of immune system to protect against disease or malignency Immunodeficiency is of two types Primary Secondary immunodeficiency
More informationBilateral Chest X-Ray Shadowing and Bilateral leg lesions - A case of Pulmonary Kaposi Sarcoma
Article ID: WMC005047 ISSN 2046-1690 Bilateral Chest X-Ray Shadowing and Bilateral leg lesions - A case of Pulmonary Kaposi Sarcoma Peer review status: No Corresponding Author: Dr. Mohammad Fawad Khattak,
More informationمحاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases
محاضرة مناعت مدرس المادة :ا.م. هدى عبدالهادي علي النصراوي Immunity to Infectious Diseases Immunity to infection depends on a combination of innate mechanisms (phagocytosis, complement, etc.) and antigen
More informationFungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*
P Fungi More or Less Obligately Associated with Humans a. a few dermatophytes (the anthropophilic species ) b. Malassezia furfur c. Candida albicans d. + Lacazia (Loboa) loboi*p e. + Pneumocystis jirovecii*p
More informationEmpiric Antimicrobial Therapy in Cancer Patients *
Haematology and Blood Transfusion Vol. 29 Modem Trends in Human Leukemia VI Edited by Neth, Gallo, Greaves, Janka Springer-Verlag Berlin Heidelberg 1985 Empiric Antimicrobial Therapy in Cancer Patients
More informationEosinophilic lung diseases
Eosinophilic lung diseases Chai Gin Tsen Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital The eyes do not see what the mind does not know Not very common A high index of suspicion
More informationMICROBIOLOGY - An Overview
MICROBIOLOGY - An Overview Hieucam Phan, MD Pediatrics St. Luke s Hospital San Francisco, CA Microbiology 6/01 1 Introduction Major Achievements of Medical Sciences in the 20th Century Microbiology DNA
More informationBabak Valizadeh, DCLS
Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological
More informationCommon things are common, but not always the answer
Kevin Conroy, Joe Mackenzie, Stephen Cowie kevin.conroy@nhs.net Respiratory Dept, Darlington Memorial Hospital, Darlington, UK. Common things are common, but not always the answer Case report Cite as:
More informationESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel
CASE PRESENTATION ECCMID clinical grand round May 2014 Anat Stern, MD Rambam medical center Haifa, Israel An 18 years old Female, from Ukraine, diagnosed with acute lymphoblastic leukemia (ALL) in 2003.
More informationImmunohistochemical Confirmation of Infections
Immunohistochemical Confirmation of Infections Danny A. Milner, Jr, MD, MSc, FCAP The Brigham and Women s Hospital Harvard Medical School Boston, Masschusetts USA Judicious Use of Immunohistochemistry
More informationDiagnosis of Pneumocystis carinii
141 Diagnosis of Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus Infected Patients with Polymerase Chain Reaction: A Blinded Comparison to Standard Methods Juan Torres, 1,a Mitchell Goldman,
More informationGuillain-Barré Syndrome
Guillain-Barré Syndrome A Laboratory Perspective Laura Dunn Biomedical Scientist (Trainee Healthcare Scientist) Diagnosis of GBS GBS is generally diagnosed on clinical grounds Basic laboratory studies
More informationAilyn T. Isais-Agdeppa, MD*, Lulu Bravo, MD*
A FIVE-YEAR RETROSPECTIVE STUDY ON THE COMMON MICROBIAL ISOLATES AND SENSITIVITY PATTERN ON BLOOD CULTURE OF PEDIATRIC CANCER PATIENTS ADMITTED AT THE PHILIPPINE GENERAL HOSPITAL FOR FEBRILE NEUTROPENIA
More information심사사례 성균관의대강북삼성병원감염내과 염준섭
폐렴및호흡기질환의치료와 심사사례 성균관의대강북삼성병원감염내과 염준섭 서 론 미국 : 매년 560만명의환자발생 -- 20% 입원 사망률 - 외래에서치료가능한환자 : 1-5% - 입원치료가필요한환자 : 25% - 국내 ( 사망원인통계결과 ) : 2001년 ; 6.1명 /10만명, 1991년 ; 5.1명 /10만명 50-90% 가외래에서치료 30-40% 는원인을밝혀내지못함
More informationIndre Vengalyte MD¹, Regina Pileckyte MD¹, Laimonas Griskevicius MD PhD 1, 2
ASPERGILLUS GALACTOMANNAN (GM) ANTIGEN IN THE BRONCHOALVEOLAR LAVAGE (BAL) FLUID FOR THE DIAGNOSIS OF INVASIVE PULMONARY ASPERGILLOSIS (IPA) IN HEMATOLOGICAL PATIENTS Indre Vengalyte MD¹, Regina Pileckyte
More informationHIV AND LUNG HEALTH. Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital
HIV AND LUNG HEALTH Stephen Aston Infectious Diseases SpR Royal Liverpool University Hospital Introduction HIV infection exerts multiple effects on pulmonary immune responses: Generalised state of immune
More information2046: Fungal Infection Pre-Infusion Data
2046: Fungal Infection Pre-Infusion Data Fungal infections are significant opportunistic infections affecting transplant patients. Because these infections are quite serious, it is important to collect
More informationHyperimmunoglobulin E syndromes (HIES)
Hyperimmunoglobulin E syndromes (HIES) hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on hyperimmunoglobulin E syndromes (HIES). It has been produced by
More informationGOALS AND OBJECTIVES INFECTIOUS DISEASE
GOALS AND OBJECTIVES INFECTIOUS DISEASE Infectious Disease and HIV Overview: The Infectious Diseases Program at the University of Southern California prepares trainees for the management of problems in
More informationImmune Deficiency Primary and Secondary. Dr Liz McDermott Immunology Department NUH
Immune Deficiency Primary and Secondary Dr Liz McDermott Immunology Department NUH Summary Different types of Immune Deficiency Why it is important to identify immune deficiency? Diagnostic delay Antibody
More informationUnit II Problem 2 Pathology: Pneumonia
Unit II Problem 2 Pathology: Pneumonia - Definition: pneumonia is the infection of lung parenchyma which occurs especially when normal defenses are impaired such as: Cough reflex. Damage of cilia in respiratory
More informationChapter 24 The Immune System
Chapter 24 The Immune System The Immune System Layered defense system The skin and chemical barriers The innate and adaptive immune systems Immunity The body s ability to recognize and destroy specific
More informationTuberculosis Intensive
Tuberculosis Intensive San Antonio, Texas April 3 6, 2012 Tuberculosis Pathogenesis Lynn Horvath, MD April 3, 2012 Lynn Horvath, MD has the following disclosures to make: No conflict of interests No relevant
More informationEpidemiology and ecology of fungal diseases
Epidemiology and ecology of fungal diseases Healthcare Focus on: - individual - diagnosis - treatment Public Health Focus on: - population - prevention The nature of fungi Kingdom Fungi (lat. fungus, -i)
More informationTuberculosis Pathogenesis
Tuberculosis Pathogenesis Renuka Khurana, MD, MPH May 12, 2015 TB for Community Providers May 12, 2015 Phoenix, Arizona EXCELLENCE EXPERTISE INNOVATION Renuka Khurana, MD, MPH has the following disclosures
More informationReview Article Correlation between Clinical Characteristics and Chest Computed Tomography Findings of Pulmonary Cryptococcosis
Pulmonary Medicine Volume 2015, Article ID 703407, 7 pages http://dx.doi.org/10.1155/2015/703407 Review Article Correlation between Clinical Characteristics and Chest Computed Tomography Findings of Pulmonary
More informationAetiology of cavitary lung lesions in patients with HIV infection*
DOI: 10.1111/j.1468-1293.2008.00674.x r 2009 British HIV Association HIV Medicine (2009), 10, 191 198 ORIGINAL RESEARCH Aetiology of cavitary lung lesions in patients with HIV infection* C-Y Lin, w H-Y
More informationCommunity Acquired Pneumonia
April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of
More informationCritical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma
- is an acute infection of the pulmonary parenchyma - is a common infection encountered by critical care nurses when it complicates the course of a serious illness or leads to acute respiratory distress.
More informationHIV-associated Pulmonary Disease. Classic and Challenging Cases from the HIV/AIDS Clinic and Beyond QUESTION: HIV-associated Pulmonary Diseases
Classic and Challenging Cases from the HIV/AIDS Clinic and Beyond Laurence Huang, MD Professor of Medicine University of California San Francisco Chief, HIV/AIDS Chest Clinic Zuckerberg San Francisco General
More informationPathogens and the immune system
Pathogens and the immune system Veronica Leautaud, Ph.D. vl2@ rice.edu Keck Hall 224 / 232-lab Lecture 8 BIOE 301-Bioengineering and World Health Review of lecture 7 Science Science is the human activity
More informationDiagnostic Procedures for Pulmonary Infiltrates in the Compromised Host
Diagnostic Procedures for Pulmonary Infiltrates in the Compromised Host Michael Douvas, MD Heme/Onc Gerald Donowitz, MD - ID Eric Davis, MD - Pulmonary Disclosure Drs. Davis, Donowitz, and Douvas do not
More informationIs pre-emptive therapy a realistic approach?
Is pre-emptive therapy a realistic approach? J Peter Donnelly PhD, FRCPath Department of Haematology Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands Is pre-emptive therapy a realistic
More informationKEY CONCEPT Germs cause many diseases in humans.
31.1 40.1 Pathogens Infectious Diseases and Human Illness KEY CONCEPT Germs cause many diseases in humans. 31.1 40.1 Pathogens Infectious Diseases and Human Illness Germ theory states that microorganisms
More informationHYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist.
HYPER IgM SYNDROME This booklet is intended for use by patients and their families and should not replace advice from a clinical immunologist. 1 HYPER IgM SYNDROME Also available : COMMON VARIABLE IMMUNODEFICIENCY
More information